Parkinson’s Disease is Indicated by the Israeli Ministry of Health for medical cannabis treatment:
Patients undergoing anti-Parkinson’s treatment for at least one year and experiencing chronic pain or pain from stiffness, that aren’t responding to conventional treatment options.
► Medical Cannabis and Parkinson (from Prescribed Grass):
Research
The Effects of Cannabis on Hypokinetic and Hyperkinetic Movement Disorders:
76.9% reported positive effect on their general condition and mood, 64% reported improvement in pain and spasticity, 59% reported decreased tremors and improved quality of sleep.
Head Researcher: Dr. Tanya Gurevich, Movement Disorders Unit
Hospital: Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Published in Clinical Neuropharmacology: November/December 2017 - Volume 40 - Issue 6 - p 268–272
Cannabidiol: a promising drug for neurodegenerative disorders?
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Cannabidiol for the treatment of psychosis in Parkinson's disease.
Zuardi AW, Crippa JA, Hallak JE, Pinto JP, Chagas MH, Rodrigues GG, Dursun SM, Tumas V
J Psychopharmacol. 2009 Nov;23(8):979-83. doi: 10.1177/0269881108096519. Epub 2008 Sep 18
Department of Neuropsychiatry and Medical Psychology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. [email protected]
https://www.ncbi.nlm.nih.gov/pubmed/18801821.
Beneficial and adverse effects of cannabidiol in a Parkinson patient with sinemet-induced dystonic dyskinesia.
Snider SR, Consroe P
Neurology 1985;35(Suppl):201
Improvement of dyskinesia
https://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=142
Recent developments in the therapeutic potential of cannabinoids.
Corey S. Department of Pharmacology and Toxicology, Institute of Neurobiology, Medical Sciences Campus University of Puerto Rico, San Juan, Puerto Rico 00901. [email protected]
